SKIP TO
CONTENT
Six Flags Entertainment Securities Fraud Investigation
Investigation Deadline:
January 5, 2026
featured news
March 16, 2015
General
Louisiana Cardiologist Agrees to Pay $650,000 to Settle Claims of Fraud
In a landmark healthcare fraud case, one Louisiana-based cardiologist recently closed the books on a concurrent criminal-civil crackdown on his fraudulent billing and accounting practices. The doctor, along with two medical offices, recently settled the civil False Claims Act side of the matter. The settlement occurred nearly seven years after […]
March 13, 2015
General
Illinois Psychiatrist Pleads Guilty to Several Fraud Charges Involving Unlawful Kickback Schemes
In 2014, the U.S. Department of Justice settled a major kickback case involving the pharmaceutical giant Teva Pharmaceuticals. As you may recall, Teva Pharmaceuticals was alleged to have offered lucrative kickbacks in the form of “consulting fees,” vacations, and other incentives to psychiatrists and treating physicians in exchange for their […]
March 12, 2015
General
Creative Medicare Fraud Scheme Gets Busted in South Florida
The scheme at issue in today’s post may get points for creativity, but it wasn’t enough to evade the healthcare fraud task force charged with punishing and deterring wasteful and illegal misconduct. In today’s case, we discuss a recent settlement involving two South Florida healthcare practitioners and their wives accused […]
March 11, 2015
General
Aluminum Importers Agree to Settle False Claims Act Allegations Involving Duties Evasion
Three U.S.-based importers of aluminum products, including California-based C.R. Laurence Co. Inc., Florida-based Southeastern Aluminum Products Inc., and Texas-based Waterfall Group LLC have agreed to pay a total of $3 million to settle allegations of evading proper customs payments for the importation of aluminum extrusions from China. Companies that cheat […]
March 10, 2015
General
AstraZeneca Settles False Claims Act Allegations Involving Unlawful Kickbacks
Known as the “purple pill,” AstraZeneca’s Nexium is a breakthrough drug targeting the symptoms of acid reflux disease, including painful and damaging esophageal burning and pain. However, according to recent allegations revealed in a Department of Justice press release, the company may have gone to too far to ensure its […]
Contact UsFree Case Evaluation
"*" indicates required fields
By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.
featured investigations
$2.4B+
in 2025 post-trial judgments
$50B+
in Settlements & Verdicts
55+
Years of Experience With High-Profile Cases
100+
Attorneys Protecting Your Rights
20+
Years Ranked as Top Law Firm by Chambers USA
50
States in Which The Firm Has Successfully Litigated
On the Cutting Edge of the Profession
Legal Intelligencer